The proposed National Food Security Bill (NFSB), under consideration of Standing Committee of Parliament, may be reviewed for procurement and distribution of maize or corn (under coarse grains scheme) at Rs 1 per kg to intended beneficiaries. Without going into the merits and demerits of ever-increasing subsidies under NFSB, corn for human consumption is highly vulnerable to impermissible limits of fungal toxicity — called “aflatoxins (B1, B2, G1, G2)”. There are...
More »SEARCH RESULT
In a victory for India and China, WHO evolves mechanism to define counterfeit drugs-Aarti Dhar
-The Hindu The World Health Organisation (WHO) has put in place a mechanism to define counterfeit medical products. The set of definitions of sub-standard, spurious, falsely labelled, falsified and counterfeit products will be globally accepted and help to bring about uniformity in identifying such drugs, without interrupting worldwide supplies. The decision to establish a member state mechanism was taken at the World Health Assembly, the WHO's policymaking body, at a meeting held recently. The...
More »ACTA will make life saving drugs costlier for the poor-Rachit Ranjan
Joseph Munyi, a Kenyan citizen, has been living with HIV for 8 years and, much like other HIV patients, is unemployed. He has been receiving his medication free of charge on account of government programmes and outreach programmes of Medicine Sans Frontieres. His medication comes in the form of generic drugs. However, this situation may not last long as economic interests of few may end up impeding many a public spirited...
More »India's resolution on mental health adopted at World Health Assembly-Aarti Dhar
India has achieved a major victory at the just concluded 65th World Health Assembly as it managed to push through a resolution on mental health, asking member-states to acknowledge the need for a comprehensive, coordinated response to addressing mental disorders from health and social sectors at the country level. The delegates recognised these measures which include programmes to reduce stigma and discrimination, reintegration of patients into workplace and society, support...
More »A healthier India: Need to resolve conflict between drug price controls, innovation and affordable healthcare-David Taylor
The debate about essential-medicine pricing and access in India illustrates the difficulties inherent in establishing policies that serve conflicting public interests in achieving goals such as caring well and ensuring safety for all, while also pursuing financially-sustainable success in scientific innovation and trade. It highlights problems facing those interested in continuing drug and vaccines development and ensuring that, once marketed, such products contribute effectively to improving public health. Modern pharmaceuticals...
More »